The 2021 Consolidated Appropriations Act requires group health plans to submit detailed
information about prescription drug pricing and healthcare spending to the federal government.
This submission is known as the “RxDC report.” The information collected will be used to publish biannual reports on prescription drug costs.
We’ve attached some answers to frequently asked questions (FAQs) about the RxDC reporting requirement.
Prescription Drug Reporting FAQ
WGAT is here for you and is committed to helping you meet all federal compliance requirements, including the RxDC report filing. If you have any questions about this or any other requirement, please contact your account manager.